Barclays’s AnaptysBio ANAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.22M | Buy |
|
|||||
|
2025
Q1 | $1.05M | Sell |
|
|||||
|
2024
Q4 | $1.11M | Buy |
|
|||||
|
2024
Q3 | $1.49M | Buy |
|
|||||
|
2024
Q2 | $510K | Sell |
|
|||||
|
2024
Q1 | $659K | Buy |
|
|||||
|
2023
Q4 | $628K | Sell |
|
|||||
|
2023
Q3 | $647K | Sell |
|
|||||
|
2023
Q2 | $990K | Buy |
|
|||||
|
2023
Q1 | $748K | Sell |
|
|||||
|
2022
Q4 | $1.25M | Sell |
|
|||||
|
2022
Q3 | $1.24M | Buy |
|
|||||
|
2022
Q2 | $21K | Sell |
|
|||||
|
2022
Q1 | $80K | Sell |
|
|||||
|
2021
Q4 | $813K | Buy |
|
|||||
|
2021
Q3 | $319K | Buy |
|
|||||
|
2021
Q2 | $97K | Sell |
|
|||||
|
2021
Q1 | $386K | Buy |
|
|||||
|
2020
Q4 | $158K | Sell |
|
|||||
|
2020
Q3 | $292K | Sell |
|
|||||
|
2020
Q2 | $534K | Sell |
|
|||||
|
2020
Q1 | $2.52M | Buy |
|
|||||
|
2019
Q4 | $466K | Buy |
|
|||||
|
2019
Q3 | $984K | Sell |
|
|||||
|
2019
Q2 | $1.87M | Buy |
|
|||||
|
2019
Q1 | $1.48M | Buy |
|
|||||
|
2018
Q4 | $911K | Sell |
|
|||||
|
2018
Q3 | $12.4M | Buy |
|
|||||
|
2018
Q2 | $890K | Buy |
|
|||||
|
2018
Q1 | $924K | Buy |
|
|||||
|
2017
Q4 | $285K | Buy |
|
|||||
|
2017
Q3 | $10K | Sell |
|
|||||
|
2017
Q2 | $12K | Sell |
|
|||||
|
2017
Q1 | $26K | Buy |
|